Literature DB >> 10884821

Withholding or withdrawal of life-sustaining therapy.

T J Prendergast1.   

Abstract

Seventy percent of deaths in intensive care units are preceded by decisions to limit life-support, most of which are made in consultation with the patient's family or other surrogates. Even when the outcome is clear, surrogates and physicians may deny that death is imminent and delay removing ventilatory assistance and other supportive measures. To avoid prolonging suffering, end-of-life decisions should always be guided by the interests and wishes of the patient.

Entities:  

Mesh:

Year:  2000        PMID: 10884821

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  4 in total

1.  Nurse involvement in end-of-life decision making: the ETHICUS Study.

Authors:  Julie Benbenishty; Freda DeKeyser Ganz; Anne Lippert; Hans-Henrik Bulow; Elisabeth Wennberg; Beverly Henderson; Mia Svantesson; Mario Baras; Dermot Phelan; Paulo Maia; Charles L Sprung
Journal:  Intensive Care Med       Date:  2005-11-16       Impact factor: 17.440

2.  Storytelling in the Early Bereavement Period to Reduce Emotional Distress Among Surrogates Involved in a Decision to Limit Life Support in the ICU: A Pilot Feasibility Trial.

Authors:  Amber E Barnato; Yael Schenker; Greer Tiver; Mary Amanda Dew; Robert M Arnold; Eduardo R Nunez; Charles F Reynolds
Journal:  Crit Care Med       Date:  2017-01       Impact factor: 7.598

3.  Decisions to forgo life-sustaining therapy in ICU patients independently predict hospital death.

Authors:  Elie Azoulay; Frédéric Pochard; Maité Garrouste-Orgeas; Delphine Moreau; Laurent Montesino; Christophe Adrie; Arnaud de Lassence; Yves Cohen; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2003-10-07       Impact factor: 17.440

4.  Life-sustaining treatment decisions in the ICU for patients with ESLD: a prospective investigation.

Authors:  Lissi Hansen; Nancy Press; Susan J Rosenkranz; Judith Gedney Baggs; Judith Kendall; Amanda Kerber; Angel Williamson; Mark S Chesnutt
Journal:  Res Nurs Health       Date:  2012-05-11       Impact factor: 2.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.